Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJun 18, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 18, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 14, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 14, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 13, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 7, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 7, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 7, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 7, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 7, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 7, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 7, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 7, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 6, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 18, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 18, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2018View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-108

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information